DUSA Pharmaceuticals, Inc.’s (DUSA) share price has entered into oversold territory with a stochastic value of 17.4037. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 1 cent over the past month to 41 cents per share. DUSA Pharmaceuticals, Inc. is a Zacks #1 Rank (“ Strong Buy”) company.
More From Zacks.com
- Investment & Company Information
- DUSA Pharmaceuticals